
Cypress Pharmaceuticals Private Limited
Pharmaceutical company that formulates, distributes, and markets drugs, cosmetics, and medicinal preparations.
Pharmaceutical company that formulates, distributes, and markets drugs, cosmetics, and medicinal preparations.
Cypress Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2017 (Eight years and two months 4 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.38 Cr and a paid-up capital of Rs 1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lav Kumar and Rakesh Ranjan serve as directors at the Company.
Thane, Maharashtra, India
+91-XXXXXXXXXX
U74999MH2017PTC292146
292146
Private Limited Indian Non-Government Company
07 Mar 2017
31 Dec 2020
31 Mar 2020
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lav Kumar ![]() | Director | Current | |
Rakesh Ranjan ![]() | Director | 26-Aug-2019 | Current |
Cypress Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 83.81% decrease. The company also saw a substantial fall in profitability, with a 19.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 118.92%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Cypress Pharmaceuticals had a promoter holding of 7.52% and a public holding of 92.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Lav Kumar and Rakesh Ranjan are mutual person
Lav Kumar and Rakesh Ranjan are mutual person
Lav Kumar and Rakesh Ranjan are mutual person
Rakesh Ranjan is a mutual person
Rakesh Ranjan is a mutual person
Rakesh Ranjan is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cypress Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cypress Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cypress Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cypress Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Cypress Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai.
Rakesh Kumar Ranjan was appointed as a Director was appointed as a Director on 26 Aug 2019 & has been associated with this company since 5 years 8 months .
Cypress Pharmaceuticals Private Limited was registered on 07 Mar 2017 with Roc Mumbai & aged 8 years 2 months as per MCA records.
Cypress Pharmaceuticals Private Limited was incorporated on 07 Mar 2017.
The authorized share capital of Cypress Pharmaceuticals Private Limited is ₹ 1.38 Cr and paid-up capital is ₹ 1.30 Cr.
Currently 2 directors are associated with Cypress Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cypress Pharmaceuticals Private Limited is Flat No. F/604 Elite Building Kalyan Shil Road, Nilje India, Mumbai, Maharashtra, 421203.
The corporate identification number (CIN) of Cypress Pharmaceuticals Private Limited is U74999MH2017PTC292146 and the company number is 292146 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Cypress Pharmaceuticals Private Limited has fallen by -83.81%.
The financial reports for the fiscal year 2020 indicates that The net worth of Cypress Pharmaceuticals Private Limited has experienced an downturn of -118.92%.
The most recent Balance Sheet for Cypress Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2020.
Search company & director profiles for free and gain access to critical business data.
RP
SP
OP